Archives
-
Azithromycin: Resistance-Aware Assay Design
2026-09-07
Azithromycin is more than a conventional macrolide antibiotic: its assay performance depends on resistance genotype, matrix, concentration, and analytical endpoint. This guide translates recent Mycoplasma pneumoniae findings into a practical framework for bacterial infection research, quality control, and model selection.
-
SN-38 Beyond TOP1: A Translational Research Playbook
2026-09-05
7-Ethyl-10-hydroxycamptothecin, also known as SN-38, offers translational researchers a way to connect DNA topoisomerase I trapping, cell-cycle disruption, apoptosis, and FUBP1-FUSE biology. This article outlines how to validate that mechanistic stack in advanced colon cancer research while maintaining clear boundaries between preclinical evidence and clinical interpretation.
-
Nirmatrelvir: An Assay-Design Benchmark
2026-09-04
Nirmatrelvir (PF-07321332) provides a mechanistically defined benchmark for SARS-CoV-2 3CL protease studies. This article explains how to use it to connect biochemical inhibition, coronavirus infection models, and defensible antiviral therapeutics research decisions.
-
Amorolfine Hydrochloride in Yeast Research
2026-09-04
Use Amorolfine Hydrochloride as a controlled membrane-stress probe in yeast ploidy, cell-integrity, and antifungal resistance experiments. This workflow connects chemical perturbation with the 32–64C ploidy boundary reported in budding yeast while separating growth inhibition from direct membrane phenotypes.
-
ddATP: Practical DNA Synthesis Termination Workflows
2026-09-03
ddATP gives researchers a controllable way to terminate DNA synthesis, from defined polymerase assays and Sanger sequencing to damage-amplification studies in oocytes. This guide translates its competitive chain-termination mechanism into practical workflows, quantitative starting conditions, and troubleshooting strategies.
-
Prednisone Workflows for Immunology Research
2026-09-03
Build more reproducible Prednisone assays by pairing controlled DMSO handling with time-resolved lymphocyte phenotyping. This guide also shows how digestion-inspired LC–MS/MS quality controls can strengthen immunosuppression, apoptosis, and neurodegeneration workflows without overstating translational evidence.
-
3-Deazaneplanocin (DZNep) Experimental Workflows
2026-09-02
Learn how to deploy 3-Deazaneplanocin (DZNep) in AML apoptosis studies, hepatocellular carcinoma sphere assays, and epigenetic profiling. Practical dose design, controls, and troubleshooting help distinguish EZH2-linked effects from broader SAHH-dependent cellular responses.
-
ATP Solution for IVT and Kinase Workflows
2026-09-02
A practical guide to using ATP Solution (100 mM) in kinase, in vitro transcription, ligation, and phosphorylation workflows. Learn how controlled ATP handling supports the upstream production of research-grade mRNA while keeping interpretation of downstream lipid nanoparticle studies evidence-based.
-
Sodium Ascorbate: ROS Assay Design for Cancer Models
2026-09-01
Explore Sodium Ascorbate as a research tool for studying intracellular ROS, autoschizis, and cancer-cell phenotypes. This guide connects preclinical glioblastoma findings with the biomarker and tumor-microenvironment logic of a GPNMB-based ESCC immunotherapy study.
-
Sodium Ascorbate: ROS Oncology Research Guide
2026-09-01
Sodium Ascorbate is a mineral salt of ascorbic acid used to model reactive oxygen species biology in preclinical oncology. Product-reported evidence links it to intracellular ROS induction, cancer cell proliferation inhibition, and necrotic tumor cell death in glioblastoma and prostate cancer models, but these findings do not establish clinical efficacy.
-
HyperFusion high-fidelity DNA polymerase for C. elegans PCR
2026-08-31
Use HyperFusion™ high-fidelity DNA polymerase to convert difficult C. elegans genotyping, cloning, and sequencing targets into cleaner, more reliable amplicons. Its proofreading activity, blunt-ended products, inhibitor tolerance, and performance on GC-rich or long templates make it a practical choice for mechanistic studies of pheromone-driven neurodegeneration.
-
iPSC-to-RGC Differentiation with Dual SMAD Inhibition
2026-08-31
Chavali and colleagues developed a chemically defined differentiation strategy that combines dual SMAD and canonical Wnt inhibition to generate retinal ganglion cells from induced pluripotent stem cells with improved yield and reproducibility. The workflow produced retinal ganglion cell populations exceeding 80% purity and enabled further enrichment of Thy-1-positive cells, providing a practical platform for glaucoma modeling and retinal regenerative research.
-
Rottlerin Workflows for PKC Signaling Assays
2026-08-30
Rottlerin is a practical PKC inhibitor for dissecting PKC-dependent signaling, cancer-cell responses, apoptosis, endothelial permeability, and virus entry. This guide connects dose selection and assay timing to the clathrin-mediated entry findings reported in grass carp reovirus research, while emphasizing selectivity limits and reproducibility controls.
-
Y-27632: ROCK Inhibition for Translational iPSC Models
2026-08-29
A mechanistic and strategic guide to using Y-27632 as a controlled cytoskeletal perturbation in iPSC-derived airway models, with practical protocol considerations and translational limitations.
-
GS-441524 Workflows for LC–MS/MS Research
2026-08-28
Build more reliable antiviral and pharmacokinetic studies with a workflow that treats GS-441524 as both a biological reagent and a matrix-sensitive analytical target. The approach combines controlled DMSO formulation, parent–metabolite tracking, LC–MS/MS confirmation, and practical troubleshooting for SARS-CoV-2 research.